Skip to main content

Table 2 Antimicrobial susceptibility profiles of the K. pneumoniae and E. coli strains used in this study

From: Co-introduction of plasmids harbouring the carbapenemase genes, blaNDM-1 and blaOXA-232, increases fitness and virulence of bacterial host

Strain

MIC (mg/L) (antimicrobial susceptibility category)a, b

IMI

MRP

CTX

CAZ

AMP

GEN

AMK

CIP

TET

SXT

P/T

CL

Donor (K. pneumoniae M5)

> 64 (R)

> 64 (R)

> 128 (R)

> 64 (R)

> 64 (R)

> 64 (R)

> 128 (R)

> 64 (R)

8 (I)

> 32/608 (R)

> 256/4 (R)

0.5 (S)

Recipient (E. coli DH5α)

0.125 (S)

0.06 (S)

0.125 (S)

0.5 (S)

4 (S)

1 (S)

4 (S)

0.06 (S)

0.5 (S)

0.25/4.75 (S)

4/4 (S)

0.06 (S)

DH5α::pM5_NDM

4 (R)

0.5 (S)

> 128 (R)

> 64 (R)

> 64 (R)

> 64 (R)

> 128 (R)

0.06 (S)

0.5 (S)

> 32/608 (R)

> 256/4 (R)

0.125 (S)

DH5α::pM5_OXA

1 (S)

0.25 (S)

4 (S)

0.5 (S)

> 64 (R)

4 (S)

16 (S)

0.06 (S)

0.5 (S)

2/38 (S)

> 256/4 (R)

0.06 (S)

DH5α::pM5_NDM

+pM5_OXA

4 (R)

1 (S)

> 128 (R)

> 64 (R)

> 64 (R)

> 64 (R)

> 128 (R)

0.06 (S)

0.5 (S)

> 32/608 (R)

> 256/4 (R)

0.06 (S)

  1. aIMI imipenem, MRP meropenem, CTX cefotaxime, CAZ ceftazidime, AMP ampicillin, GEN gentamicin, AMK amikacin, CIP ciprofloxacin, TET tetracycline, SXT trimethoprim-sulfamethoxazole, P/T piperacillin-tazobactam, CL colistin
  2. bR resistant, I intermediate-resistant, S susceptible